Smith & Nephew (NYSE:SNN;LSE:SN), the global medical technology business, today launched its new EVOS MINI Plating System for use in complex fractures of the long bones of the arms and legs. Designed specifically for traumatologists, this long-bone-specific system includes the variety of mini, flat plates and screw sizes necessary to address both fracture reduction and short-term fixation while the final, load-bearing repair is being completed.
A growing trend among traumatologists involves reducing long bone fractures using a mini fragment system designed for either the hand or foot. However, because the plates in these traditional systems are designed for the more rounded shape of the body’s small bones, surgeons often have to modify the plates. Additionally, because they are meant to be used on the smaller, thinner bones of the hand and foot, the screws designed for these systems are often too short to use in larger, dense long bones like the thigh or forearm.
“Simply put, the right tools make any job easier,” explains Brad Cannon, President, Endoscopy, Trauma and Extremities for Smith & Nephew. “With our new EVOS MINI Plating System, surgeons now have a robust, small plating system designed specifically for the challenging size and shape of long bones.”
Organized into a single tray, each EVOS MINI Plating System includes three different, color-coded, size modules that offer a variety of up to eight low-profile plate geometries. Along with the plates, each module also offers the instrumentation for implementing the corresponding low-profile screw options for cortical, cancellous and osteopenic bone. With sizes up to 80mm, the system’s screws also offer variable-angle locking technology which allows placement of a locking screw up to 15-degrees off-axis.
“The set design is optimized to follow the flow of surgery,” said Dr William Ricci, Chief of Orthopaedic Trauma at Washington University in St. Louis. “Surgeons and nurses will appreciate that all the plate options are easy to see in a single tray and the color-coding helps quickly locate the corresponding instruments and screws in their modular caddy. The simplicity of the system goes even further by introducing a unique, stair-step design for its screw caddy that assures all screws loaded are the appropriate size; potentially reducing errors in central supply by eliminating the need to measure each screw.”
Surgeons wanting to see the EVOS MINI Plating System first-hand can visit the Smith & Nephew booth (#302) at this week’s Orthopaedic Trauma Association meeting.
Contacts:
|
Media |
|
|
Joe Metzger
|
|
|
Investor/Analyst |
|
|
Ingeborg Oie |
+44 (0)20 7401 7646 |
About Smith & Nephew
Smith & Nephew is a global medical technology business dedicated to helping healthcare professionals improve people's lives. With leadership positions in Orthopaedic Reconstruction, Advanced Wound Management, Sports Medicine and Trauma & Extremities, Smith & Nephew has around 14,000 employees and a presence in more than 90 countries. Annual sales in 2013 were more than $4.3 billion. Smith & Nephew is a member of the FTSE100 (LSE: SN, NYSE: SNN).
For more information about Smith & Nephew, please visit our corporate website www.smith-nephew.com, follow @SmithNephewplc on Twitter or visit SmithNephewplc on Facebook.com
Forward-looking Statements
This document may contain forward-looking statements that may or may not prove accurate. For example, statements regarding expected revenue growth and trading margins, market trends and our product pipeline are forward-looking statements. Phrases such as "aim", "plan", "intend", "anticipate", "well-placed", "believe", "estimate", "expect", "target", "consider" and similar expressions are generally intended to identify forward-looking statements. Forward-looking statements involve known and unknown risks, uncertainties and other important factors that could cause actual results to differ materially from what is expressed or implied by the statements. For Smith & Nephew, these factors include: economic and financial conditions in the markets we serve, especially those affecting health care providers, payers and customers; price levels for established and innovative medical devices; developments in medical technology; regulatory approvals, reimbursement decisions or other government actions; product defects or recalls; litigation relating to patent or other claims; legal compliance risks and related investigative, remedial or enforcement actions; strategic actions, including acquisitions and dispositions, our success in performing due diligence, valuing and integrating acquired businesses; disruption that may result from transactions or other changes we make in our business plans or organisation to adapt to market developments; and numerous other matters that affect us or our markets, including those of a political, economic, business, competitive or reputational nature. Please refer to the documents that Smith & Nephew has filed with the U.S. Securities and Exchange Commission under the U.S. Securities Exchange Act of 1934, as amended, including Smith & Nephew's most recent annual report on Form 20-F, for a discussion of certain of these factors. Any forward-looking statement is based on information available to Smith & Nephew as of the date of the statement. All written or oral forward-looking statements attributable to Smith & Nephew are qualified by this caution. Smith & Nephew does not undertake any obligation to update or revise any forward-looking statement to reflect any change in circumstances or in Smith & Nephew's expectations.
◊ Trademark of Smith & Nephew. Certain marks registered US Patent and Trademark Office.